miscsubjectsAI governance
Evidence review · standard

ss 31

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why it would work (logic chain)

No mechanism chain catalogued yet.

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 0 anecdote source(s) (posts, threads, comments)
  • 0 anecdote-tier claim(s) derived from them

Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 8
  • Claims tagged human evidence: 0
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 8

Logic: Studies exist in the ledger, but none are graded as strong human proof for the uses people discuss online. Animal and lab work is not the same as proof in people.

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.2 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential (source s1)

2025 review on structure, mechanism, and therapeutic potential of elamipretide/SS-31.

Evidence type: Published research.

SS-31: A promising therapeutic agent against bleomycin-induced pulmonary fibrosis (source s2)

2025 study on SS-31 for pulmonary fibrosis.

Evidence type: Published research.

Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval (source s3)

2026 review on FDA approval of elamipretide for Barth syndrome.

Evidence type: Published research.

Elamipretide (SS-31) Promotes Recovery by Preserving Mitochondrial Bioenergetics and Neural Remodeling after Spinal Cord Injury (source s4)

2026 study on SS-31 for spinal cord injury recovery.

Evidence type: Published research.

Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high ... (source s5)

2025 preclinical evaluation of SS-31/elamipretide for aging-related cerebral issues.

Evidence type: Published research.

Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction (source s6)

2024 review on SS-31 applications for mitochondrial dysfunction, including clinical trials overview.

Evidence type: Published research.

Effect of Elamipretide on the Vitrification of Mouse Ovarian ... (source s7)

2024 study showing SS-31 protects ovarian tissue during cryopreservation via mitochondrial and antioxidant effects.

Evidence type: Published research.

Mitochondrial antioxidant elamipretide improves learning ... (source s8)

2024 study on elamipretide improving learning and memory.

Evidence type: Published research.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Ss 31 · peptide map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 8 sources · swipe →chain b3df080ff836 · verify chain · provenance
1 / 8
Model review3 contributions · 1 modelExpand the recursive review layer
1 / 3
grok-4.3writer
draft2026-06-29 16:49
ss 31
inspect — what it was prompted & output
prompted with
(default writer prompt)
c0d0dabc3c0ebe60
grok-4.3source_hunt
sources2026-06-29 16:50
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ss-31
it output
4 source(s) added
f91bd1b1284928b2
grok-4.3source_hunt
sources2026-06-29 16:50
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: ss-31
it output
4 source(s) added
fdc9b92588c0add7
Machine verification: /api/articles/ss-31/contributions
Ask this article · 2 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

For my medical situation, what can you answer from your catalogue about ss 31 — and what would you need me to tell you first?
ask ss-31 condition gaps · paste includes §SELF
What good and bad outcomes are documented for ss 31 (studies vs anecdotes)?
ask ss-31 good bad experiences · paste includes §SELF
ss-31 · posted 2026-06-29 · updated 2026-07-17 · 2 prior revisions
Ledger API & provenance
Provenance · 4 model passes · 0 tokens · $0 · 2 models
chain head 66db891e5936ddf6
populate-init grok-4.3 · 2026-06-29 16:49 · 0 tok · 8a61c89b1991
sources grok-4.3 · 2026-06-29 16:50 · 0 tok · f41fc840eb7b
sources grok-4.3 · 2026-06-29 16:50 · 0 tok · af6ba401e9d3
voxel_divide owner · 2026-07-17 02:42 · 0 tok · 66db891e5936
verify chain →
Live ledger · 48 payloads · 3 turns
recent activity · inspect
LEADS_DRAFT_AI dispatch · 2026-07-23 13:25 · t_wuxhrnl5
LEADS_DRAFT_AI dispatch · 2026-07-23 13:25 · t_wuxhrnl5
LEADS_DRAFT_AI mcp · HTTP 200 · 2026-07-23 13:25 · t_wuxhrnl5
LEADS_DRAFT_AI dispatch · 2026-07-23 11:46 · t_1n0bnlxq
LEADS_DRAFT_AI dispatch · 2026-07-23 11:46 · t_1n0bnlxq
LEADS_DRAFT_AI mcp · HTTP 200 · 2026-07-23 11:46 · t_1n0bnlxq
view full ledger & cards →
REST + ledger
read GET /api/articles/ss-31 · GET /api/articles/ss-31?format=post (the editable body)
create/replace POST /api/articles/ss-31 · PUT /api/articles/ss-31 (replace, keeps revision) · PATCH /api/articles/ss-31 (merge)
delete DELETE /api/articles/ss-31
writes need header x-terminal-key
LLM bundle GET /api/articles/ss-31/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim ss-31|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…